Success Metrics

Clinical Success Rate
100.0%

Based on 5 completed trials

Completion Rate
100%(5/5)
Active Trials
0(0%)
Results Posted
20%(1 trials)

Phase Distribution

Ph phase_1
3
50%
Ph early_phase_1
3
50%

Phase Distribution

6

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
3(50.0%)
Phase 1Safety & dosage
3(50.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

83.3%

5 of 6 finished

Non-Completion Rate

16.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Completed(5)
Terminated(1)

Detailed Status

Completed5
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 13 (50.0%)
Phase 13 (50.0%)

Trials by Status

completed583%
withdrawn117%

Recent Activity

0 active trials
Showing 5 of 6
completedphase_1

Imaging Regional Lung Defect Severity

NCT01640288
completedearly_phase_1

Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)

NCT03237364
completedearly_phase_1

19F Thoracic Radiotherapy for Lung Cancer

NCT03315065
withdrawnearly_phase_1

Comparison of 133Xe Scintigraphy With 19F MRI

NCT03532334
completedphase_1

Lung Transplant Subjects Using 19F MRI

NCT02019251
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT01640288Phase 1

Imaging Regional Lung Defect Severity

Completed
NCT03237364Early Phase 1

Iraq- Afghanistan War Lung Injury Using 19F MRI (DIAL1001006)

Completed
NCT03315065Early Phase 1

19F Thoracic Radiotherapy for Lung Cancer

Completed
NCT03532334Early Phase 1

Comparison of 133Xe Scintigraphy With 19F MRI

Withdrawn
NCT02019251Phase 1

Lung Transplant Subjects Using 19F MRI

Completed
NCT01710449Phase 1

Evaluation of Regional Ventilation Using 19F MRI of Inert Perfluorinated Gases Mixed With Oxygen

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6